October 2015 Briefing - Hematology & Oncology

Share this content:

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for October 2015. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Synchronized Prescription Renewal Process Saves Time

FRIDAY, Oct. 30, 2015 (HealthDay News) -- A synchronized prescription renewal process can save physicians time and money, which can be dedicated to patient care, according to a report from the American Medical Association (AMA).

More Information

Increasing Numbers of Med School Applicants, Enrollees

FRIDAY, Oct. 30, 2015 (HealthDay News) -- There has been a 25 percent increase in the number of medical school enrollees since 2002, with the number reaching an all-time high of 20,630 this year, according to a report published online Oct. 22 by the Association of American Medical Colleges (AAMC).

More Information

Dose-Response Pattern for Smoking, Colorectal Neoplasm

FRIDAY, Oct. 30, 2015 (HealthDay News) -- Colorectal neoplasm (CRN) is associated with smoking in a dose-response manner, but not with alcohol intake, according to a study published online Oct. 19 in the Journal of Gastroenterology and Hepatology.

Abstract
Full Text (subscription or payment may be required)

CDC: Not Enough Young Girls Getting HPV Vaccination

THURSDAY, Oct. 29, 2015 (HealthDay News) -- Human papillomavirus (HPV) vaccination rates among American girls remain too low, according to research published in the Oct. 30 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Full Text

FDA Approves Expanded Use for Melanoma Drug

THURSDAY, Oct. 29, 2015 (HealthDay News) -- The melanoma drug Yervoy (ipilimumab) can now be used to reduce the risk of the recurrence after surgery, the U.S. Food and Drug Administration said Thursday.

More Information

Ovarian Cancer Rx Promising for Prostate Tumors

THURSDAY, Oct. 29, 2015 (HealthDay News) -- Lynparza (olaparib) targets mutations found in about 30 percent of men with prostate cancer, but may also benefit men whose tumors have acquired defects in DNA repair, according to research published in the Oct. 29 issue of the New England Journal of Medicine.

Abstract
Full Text

Some RA Treatments Up Second Nonmelanoma Skin Cancer Risk

THURSDAY, Oct. 29, 2015 (HealthDay News) -- For patients with rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) with prior nonmelanoma skin cancer (NMSC), the risk of second NMSC varies with different treatments, according to a study published online Oct. 28 in JAMA Dermatology.

Abstract
Full Text (subscription or payment may be required)

Review Supports LMWH for Cancer-Linked Incidental PE

THURSDAY, Oct. 29, 2015 (HealthDay News) -- Cancer-associated incidental pulmonary embolism (IPE) should be treated with low molecular weight heparins (LMWHs), according to a review published online Oct. 15 in the Journal of Thrombosis and Haemostasis.

Abstract
Full Text (subscription or payment may be required)

CDC: E-Cigarette Use Highest Among 18- to 24-Year-Olds

WEDNESDAY, Oct. 28, 2015 (HealthDay News) -- Nearly 13 percent of American adults have tried electronic cigarettes (e-cigarettes) at least once, and 3.7 percent currently use them, according to the 2014 National Health Interview Survey by the U.S. Centers for Disease Control and Prevention.

More Information

FDA Approves Imlygic for Melanoma

WEDNESDAY, Oct. 28, 2015 (HealthDay News) -- Imlygic (talimogene laherparepvec) has been approved by the U.S. Food and Drug Administration to treat melanoma lesions of the skin and lymph nodes.

More Information

Internal Mammary Lymph Nodes ID'd on MRI Likely to Be Benign

WEDNESDAY, Oct. 28, 2015 (HealthDay News) -- Among women with breast cancer and silicone implant reconstruction, internal mammary lymph nodes (IMLNs) identified at implant-protocol breast magnetic resonance imaging (MRI) are more likely to be benign than malignant, according to a study published in the November issue of Radiology.

Full Text (subscription or payment may be required)

Low BMI Linked to Increased Risk of Progression, Death in mCRC

WEDNESDAY, Oct. 28, 2015 (HealthDay News) -- For patients enrolled in metastatic colorectal cancer (mCRC) trials, low body mass index (BMI) is associated with increased risk of progression and death, according to research published online Oct. 26 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)

Nearly 15 Percent of Plans Lack In-Network Specialists

WEDNESDAY, Oct. 28, 2015 (HealthDay News) -- A considerable proportion of federal marketplace plans lack at least one in-network specialist, according to a research letter published in the Oct. 27 issue of the Journal of the American Medical Association.

Full Text (subscription or payment may be required)

Fatal Case of Hidradenitis Suppurativa Described

WEDNESDAY, Oct. 28, 2015 (HealthDay News) -- Hidradenitis suppurativa (HS) can be associated with infectious and/or neoplastic fatal complications, according to a case report published online Oct. 16 in the International Journal of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Physician Emphasizes Importance of Saying Thank You

TUESDAY, Oct. 27, 2015 (HealthDay News) -- The importance of thanking patients for coming to see you, the physician, is described in an essay published online in Medical Economics.

Full Text

Risk of More Aggressive Ductal Carcinoma in Situ Rises With Age

TUESDAY, Oct. 27, 2015 (HealthDay News) -- Ductal carcinoma in situ (DCIS) is much more likely to be aggressive when discovered in older women, according to a report published online Oct. 27 in Radiology.

Abstract
Full Text

Mortality Rates for Major Illnesses Fall in the United States

TUESDAY, Oct. 27, 2015 (HealthDay News) -- Fewer Americans are dying from cardiovascular disease, cancer, stroke, diabetes, and injuries, a new study reveals. The report was published in the Oct. 27 issue of the Journal of the American Medical Association.

Abstract
Full Text
Editorial (subscription or payment may be required)

Continuing Mailed FOBT Program Ups CRC Screening Adherence

TUESDAY, Oct. 27, 2015 (HealthDay News) -- Continuing a centralized mailed fecal occult blood test (FOBT) program is beneficial for improving adherence to colorectal cancer (CRC) screening, according to a study published online Oct. 21 in Cancer.

Abstract
Full Text (subscription or payment may be required)

Oxidative Stress Inhibits Metastasis by Melanoma Cells

TUESDAY, Oct. 27, 2015 (HealthDay News) -- Oxidative stress inhibits metastasis by melanoma cells, according to an experimental study published online Oct. 14 in Nature.

Abstract
Full Text (subscription or payment may be required)

Transoral Robotic Surgery Feasible for Oropharyngeal SCC

TUESDAY, Oct. 27, 2015 (HealthDay News) -- For patients with oropharyngeal squamous cell carcinoma (SCC), transoral robotic surgery is feasible, according to a study published in the November issue of Head & Neck.

Abstract
Full Text (subscription or payment may be required)

CDC: Too Few Male Adolescents Receiving HPV Vaccine

MONDAY, Oct. 26, 2015 (HealthDay News) -- Most male adolescents in the United States aren't receiving the human papillomavirus (HPV) vaccine alongside their other scheduled inoculations, largely because doctors fail to recommend it or adequately explain its benefits to parents, according to a report published online Oct. 26 in Pediatrics.

Abstract
Full Text

WHO: Evidence That Processed Meat Can Cause Cancer

MONDAY, Oct. 26, 2015 (HealthDay News) -- Processed meats, such as bacon, hot dogs, and sausages, are carcinogenic, and red meat may be as well, experts from the World Health Organization (WHO) warned on Monday. The findings were published online Oct. 26 in The Lancet Oncology.

Abstract
Full Text (subscription or payment may be required)

Inferior Care, Higher Costs for Black Men With Prostate Cancer

MONDAY, Oct. 26, 2015 (HealthDay News) -- Older black men with prostate cancer seem more likely to receive poorer quality of care that costs more compared to white men, according to a report published online Oct. 22 in JAMA Oncology.

Abstract
Full Text
Editorial

Sartans Improve Survival, Time to Recurrence in Liver Cancer

MONDAY, Oct. 26, 2015 (HealthDay News) -- For patients with hepatocellular carcinoma after radiofrequency ablation, angiotensin II receptor 1 blockers (sartans) correlate with significantly improved overall survival and time to recurrence, according to a study published in the November issue of the Journal of Gastroenterology and Hepatology.

Abstract
Full Text (subscription or payment may be required)

Case of Basal Cell Carcinoma Described Within Port Wine Stain

MONDAY, Oct. 26, 2015 (HealthDay News) -- A case of basal cell carcinoma (BCC) has been described within a port wine stain (PWS), with no preceding treatment, according to a case report published in the October issue of The Journal of Dermatology.

Abstract
Full Text (subscription or payment may be required)

AMA: Eight Reasons for Nonadherence to Medications

FRIDAY, Oct. 23, 2015 (HealthDay News) -- Eight reasons associated with patient's intentional nonadherence to medications have been identified in a report published by the American Medical Association (AMA).

More Information

FDA Approves Yondelis for Soft-Tissue Sarcoma

FRIDAY, Oct. 23, 2015 (HealthDay News) -- The chemotherapy drug Yondelis (trabectedin) has been approved by the U.S. Food and Drug Administration to treat certain advanced or unresectable soft-tissue sarcomas (STS).

More Information

FDA Approves Onivyde for Metastatic Pancreatic Cancer

FRIDAY, Oct. 23, 2015 (HealthDay News) -- The U.S. Food and Drug Administration has approved Onivyde (irinotecan liposome injection) to be used in combination with fluorouracil and leucovorin in advanced pancreatic cancer.

More Information

Neuromuscular Stimulation Doesn't Aid Dysphagia Patients

FRIDAY, Oct. 23, 2015 (HealthDay News) -- Neuromuscular electrical stimulation (NMES) does not add benefit to traditional swallow exercises for patients experiencing dysphagia after treatment for head and neck cancer, according to a study published online Oct. 15 in Head & Neck.

Abstract
Full Text (subscription or payment may be required)

Nicotinamide Could Protect Against Some Skin Cancers

THURSDAY, Oct. 22, 2015 (HealthDay News) -- Nicotinamide appears to reduce non-melanoma skin cancers by 23 percent when taken twice daily, according to a report published in the Oct. 22 issue of the New England Journal of Medicine.

Full Text (subscription or payment may be required)

Many Doctors Inconsistent With HPV Vaccine Recommendations

THURSDAY, Oct. 22, 2015 (HealthDay News) -- Many physicians are inconsistent or behind schedule in their recommendations for human papillomavirus (HPV) vaccination, according to a study published online Oct. 22 in Cancer Epidemiology, Biomarkers & Prevention.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

CRT May Be Preferred Strategy for Elderly With Lung Cancer

THURSDAY, Oct. 22, 2015 (HealthDay News) -- Chemoradiotherapy (CRT) is associated with survival benefit over chemotherapy (CT) alone for elderly patients with limited-stage small-cell lung cancer, according to a study published online Oct. 19 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)

FDA Approves Coagadex for Rare Clotting Disorder

WEDNESDAY, Oct. 21, 2015 (HealthDay News) -- Coagadex (coagulation Factor X) has been approved by the U.S. Food and Drug Administration as the first coagulation factor replacement therapy for people with a rare blood disorder known as hereditary Factor X deficiency.

More Information

Older Blood Appears Safe for Cardiac Surgery Patients

WEDNESDAY, Oct. 21, 2015 (HealthDay News) -- Cardiac surgery patients given blood stored for more than six weeks face no greater harm than those who get blood donated within two weeks, according to a research letter published in the Oct. 20 issue of the Journal of the American Medical Association.

Full Text (subscription or payment may be required)

Cancers Differ in Indigenous, Non-Indigenous Populations

WEDNESDAY, Oct. 21, 2015 (HealthDay News) -- In Australia, New Zealand, Canada, and the United States, indigenous populations exhibit clear differences in the scale and profile of cancer compared to non-indigenous populations, according to a study published online Oct. 14 in The Lancet Oncology.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Outpatient Spending Higher With Physician-Hospital Integration

TUESDAY, Oct. 20, 2015 (HealthDay News) -- Markets with greater increases in physician-hospital integration show greater increases in spending for outpatient care, but not inpatient care, for a large commercially insured population, according to a study published online Oct. 19 in JAMA Internal Medicine.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

ACS: Annual Mammograms Should Start at Age 45

TUESDAY, Oct. 20, 2015 (HealthDay News) -- The American Cancer Society is delaying the recommended age when a woman should start receiving annual mammograms, based on new research that shows the average risk for breast cancer increases near menopause. The new guidelines are published in the Oct. 20 issue of the Journal of the American Medical Association.

Guideline
Review
Editorial 1
Editorial 2

SNORA42 Identified as Novel Oncogene in Colorectal Cancer

TUESDAY, Oct. 20, 2015 (HealthDay News) -- For patients with colorectal cancer (CRC), SNORA42 seems to be a novel oncogene that can predict recurrence and prognosis, according to a study published online Oct. 15 in Gut.

Abstract
Full Text

Report Details Benefits, Risks of Nivolumab for Squamous NSCLC

TUESDAY, Oct. 20, 2015 (HealthDay News) -- For patients with metastatic squamous non-small-cell lung cancer (SQ NSCLC), nivolumab has been granted U.S. Food and Drug Administration approval. The benefit-risk summary was reviewed in a report published online Oct. 15 in JAMA Oncology.

Abstract
Full Text
Editorial

Not All Large Breast Tumors Warrant Mastectomy

MONDAY, Oct. 19, 2015 (HealthDay News) -- A combination of breast conservation surgery and radiation is as effective as breast removal for some women with large, localized invasive breast tumors, according to a study published online Oct. 19 in Cancer.

Abstract
Full Text (subscription or payment may be required)

FDA Approves Praxbind to Reverse Pradaxa's Effect

MONDAY, Oct. 19, 2015 (HealthDay News) -- Praxbind (idarucizumab) has been approved for use in patients who are taking the anticoagulant Pradaxa (dabigatran) when there is an urgent need to reverse Pradaxa's anticoagulant effects, according to a news release from the U.S. Food and Drug Administration.

More Information

Possible Association for Bortezomib Therapy, Chalazia

MONDAY, Oct. 19, 2015 (HealthDay News) -- There is a possible correlation between bortezomib use and chalazia, according to a report published online Oct. 15 in JAMA Ophthalmology.

Abstract
Full Text (subscription or payment may be required)

Rising Threat of Antibiotic Resistance in Surgery, Chemo

FRIDAY, Oct. 16, 2015 (HealthDay News) -- As many as half of postsurgical infections and more than a quarter of infections after chemotherapy are caused by organisms already resistant to standard antibiotics, according to a study published Oct. 15 in The Lancet Infectious Diseases.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Time-Limited Strategies Feasible for ICU Critical Cancer Care

FRIDAY, Oct. 16, 2015 (HealthDay News) -- For patients with poor-prognosis cancer, trials of intensive care unit (ICU) care of short duration may be sufficient, according to a study published online Oct. 15 in JAMA Oncology.

Abstract
Full Text
Editorial

Statistical Tool Predicts Risk of Major Post-Op Complications

FRIDAY, Oct. 16, 2015 (HealthDay News) -- A statistical tool can accurately estimate an individual patient's risk of developing a major complication after surgery for oral cavity squamous cell carcinoma, according to a study published online Oct. 15 in JAMA Otolaryngology-Head & Neck Surgery.

Abstract
Full Text (subscription or payment may be required)

Treatment Patterns for DCIS Shift From 1991 to 2010

FRIDAY, Oct. 16, 2015 (HealthDay News) -- There were substantial shifts in treatment patterns for ductal carcinoma in situ (DCIS) from 1991 to 2010, with more women opting for lumpectomy and radiation therapy rather than single mastectomy, according to a study published online Sept. 30 in the Journal of the National Cancer Institute.

Abstract
Full Text (subscription or payment may be required)

Internet Interventions Interest Informed Melanoma Patients

THURSDAY, Oct. 15, 2015 (HealthDay News) -- The melanoma patients receptive to an Internet-delivered behavioral intervention to promote skin self-examination (SSE) and sun protection behaviors may already have higher knowledge of melanoma signs, according to a research letter published online Oct. 14 in JAMA Dermatology.

Full Text (subscription or payment may be required)

Lower-Income Cancer Patients Less Likely to Participate in Trials

THURSDAY, Oct. 15, 2015 (HealthDay News) -- Lower-income patients with cancer are less likely to participate in clinical trials, according to a research letter published online Oct. 15 in JAMA Oncology.

Full Text (subscription or payment may be required)

Vitamin D, Calcium Don't Cut Recurrent Adenoma Risk

THURSDAY, Oct. 15, 2015 (HealthDay News) -- Supplemental vitamin D and calcium do not seem to reduce the risk of recurrent colorectal adenomas, according to a study published online Oct. 14 in the New England Journal of Medicine.

Full Text (subscription or payment may be required)

Lesion-Directed Screening Effectively Detects Skin Cancer

THURSDAY, Oct. 15, 2015 (HealthDay News) -- Lesion-directed screening (LDS) has a similar skin cancer detection rate as total-body examination (TBE) but is substantially less time-consuming, according to a study published online Oct. 14 in JAMA Dermatology.

Abstract
Full Text
Editorial (subscription or payment may be required)

Myopathy in Patient With Rx-Related Respiratory Symptoms

WEDNESDAY, Oct. 14, 2015 (HealthDay News) -- Administration of nivolumab can cause adverse effects, including respiratory symptoms, according to a case study published in the October issue of The Journal of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Squamous Cell Carcinoma Can Develop on Verrucous Lesions

WEDNESDAY, Oct. 14, 2015 (HealthDay News) -- Squamous cell carcinoma (SCC) can develop on long-standing verrucous lesions, according to a report published as a letter to the editor in the October issue of The Journal of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Computerized Tool Aids Cognitive Deficits in Cancer Survivors

WEDNESDAY, Oct. 14, 2015 (HealthDay News) -- Computerized cognitive training improves cognitive deficits associated with pediatric cancer treatment, according to a study published online Oct. 12 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)

Advanced-Stage Breast CA More Likely in Certain Racial Groups

TUESDAY, Oct. 13, 2015 (HealthDay News) -- Women in certain racial/ethnic groups are more likely to be diagnosed with more advanced breast cancer, according to a study published online Oct. 13 in Cancer Epidemiology, Biomarkers & Prevention.

Abstract
Full Text (subscription or payment may be required)

Cancer Survivors Often Have Poor Dietary Quality

TUESDAY, Oct. 13, 2015 (HealthDay News) -- Cancer survivors tend to have worse dietary quality than the general population, according to a study published online Oct. 13 in Cancer.

Abstract
Full Text (subscription or payment may be required)

Sorafenib, Sunitinib May Pose Cardiovascular Risk

MONDAY, Oct. 12, 2015 (HealthDay News) -- Older kidney cancer patients treated with sorafenib or sunitinib may face an increased risk of cardiovascular adverse events, according to a study published online Oct. 6 in Cancer.

Abstract
Full Text (subscription or payment may be required)

Americans Spend More on Health Care, but Fare Worse

MONDAY, Oct. 12, 2015 (HealthDay News) -- When compared to 12 other industrialized nations, Americans spend more on health care services, but they fare worst in terms of life expectancy, according to recent findings from The Commonwealth Fund.

More Information

FDA Approves Expanded Use of Opdivo in Advanced Lung Cancer

FRIDAY, Oct. 9, 2015 (HealthDay News) -- The U.S. Food and Drug Administration has approved Opdivo (nivolumab) to treat patients with advanced non-small-cell lung cancer (NSCLC) whose disease progressed despite platinum-based chemotherapy.

More Information

Occupational Risk of Bladder Cancer on the Rise

FRIDAY, Oct. 9, 2015 (HealthDay News) -- Despite efforts by lawmakers and manufacturers to protect workers and provide safe working environments, the risk of bladder cancer is still rising in certain industries, according to a review published online Oct. 8 in JAMA Oncology.

Abstract
Full Text
Editorial

Young Cancer Survivors May Need Lifelong Screenings

THURSDAY, Oct. 8, 2015 (HealthDay News) -- Teen and young adult cancer survivors are at increased risk for other cancers later in life, according to a study published online Oct. 6 in Cancer.

Abstract
Full Text (subscription or payment may be required)

Safety Concerns Raised for Antioxidant Use in Melanoma

THURSDAY, Oct. 8, 2015 (HealthDay News) -- The antioxidant N-acetylcysteine appears to accelerate the spread of skin cancer in mice, raising questions about its safety in humans, according to research published in the Oct. 7 issue of Science Translational Medicine.

Full Text (subscription or payment may be required)

Early Detection Still Key to Breast Cancer Survival

THURSDAY, Oct. 8, 2015 (HealthDay News) -- Even with recent strides in breast cancer treatment, a woman's chances of surviving the disease still partly depend on early detection, according to research published online Oct. 6 in The BMJ.

Full Text
Editorial

Most Cancer Patients Believe Surgery Will Be Curative

THURSDAY, Oct. 8, 2015 (HealthDay News) -- Most patients undergoing surgery for lung or colorectal cancer believe that the surgery is likely to be curative, according to a study published in the Oct. 15 issue of Cancer.

Abstract
Full Text (subscription or payment may be required)

Extended RAS Testing Urged Before EGFR MoAB Therapy

THURSDAY, Oct. 8, 2015 (HealthDay News) -- For patients with metastatic colorectal cancer, anti-epidermal growth factor receptor (EGFR) monoclonal antibody (MoAB) therapy should be considered only after extended RAS testing, according to a study published online Oct. 5 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)

Ovarian Tissue Transplant Can Up Fertility Post Cancer Tx

WEDNESDAY, Oct. 7, 2015 (HealthDay News) -- For cancer survivors, ovarian tissue transplants are safe and effective and pose little risk of cancer recurrence, according to a report published online Oct. 6 in Human Reproduction.

Abstract
Full Text (subscription or payment may be required)

FDA Approves Optune Device for Newly Diagnosed Glioblastoma

TUESDAY, Oct. 6, 2015 (HealthDay News) -- The U.S. Food and Drug Administration on Monday expanded its approval for the Optune device to include newly diagnosed glioblastoma multiforme.

More Information

Prognostic Disclosure Improves Life Expectancy Estimates

WEDNESDAY, Oct. 7, 2015 (HealthDay News) -- Prognostic disclosure is associated with more realistic patient expectations of life expectancy (LE) in advanced cancer, according to a study published online Oct. 5 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)

Laparoscopic Surgery May Not Be Best Option for Rectal Cancer

TUESDAY, Oct. 6, 2015 (HealthDay News) -- Minimally invasive surgery does not match standard surgery for the treatment of rectal cancer, according to two studies published in the Oct. 6 issue of the Journal of the American Medical Association.

Abstract 1
Full Text (subscription or payment may be required)
Abstract 2
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

California Governor Signs Right-to-Die Bill Into Law

TUESDAY, Oct. 6, 2015 (HealthDay News) -- California Gov. Jerry Brown signed "right-to-die" legislation on Monday that will allow the terminally ill to legally end their lives.

More Information

As HIV Patients Live Longer, Certain Cancer Risks Rise

TUESDAY, Oct. 6, 2015 (HealthDay News) -- Antiretroviral therapy has extended the lives of people with HIV, but living longer may increase these patients' risk for certain cancers, according to a study published in the Oct. 6 issue of the Annals of Internal Medicine.

Full Text (subscription or payment may be required)

USPSTF Recommends CRC Screening for 50- to 75-Year-Olds

TUESDAY, Oct. 6, 2015 (HealthDay News) -- The U.S. Preventive Services Task Force (USPSTF) recommends colorectal cancer (CRC) screening starting at age 50 years and continuing through age 75 years. These findings form the basis of a draft recommendation statement, published Oct. 5 by the USPSTF.

Evidence Review
Draft Recommendation Statement
Comment on Recommendations

Guidelines Developed for Managing Conflicts of Interest

TUESDAY, Oct. 6, 2015 (HealthDay News) -- The Guidelines International Network has developed principles for disclosure and management of conflicts of interest (COIs) during the clinical practice guideline development process, according to a report published in the Oct. 6 issue of the Annals of Internal Medicine.

Full Text (subscription or payment may be required)

High-Dose Hypofractionated RT Palliative in Head, Neck Cancer

MONDAY, Oct. 5, 2015 (HealthDay News) -- For patients with incurable head and neck cancer, high-dose hypofractionated radiotherapy (RT) is associated with meaningful palliative effect, according to a study published online Sept. 2 in Head & Neck.

Abstract
Full Text (subscription or payment may be required)

Significant Disparities in Care for Pediatric Retinoblastoma

MONDAY, Oct. 5, 2015 (HealthDay News) -- Significant disparities in care and outcomes exist for children with retinoblastoma, according to a study published online Oct. 5 in JAMA Pediatrics.

Abstract
Full Text (subscription or payment may be required)

Modified SOAP Ups Student Awareness of Health Care Costs

MONDAY, Oct. 5, 2015 (HealthDay News) -- Modification of the traditional Subjective-Objective-Assessment-Plan (SOAP) presentation to consider value (SOAP-V) can help medical students learn to practice high-value, cost-conscious care, according to a study published online Sept. 28 in the Journal of Hospital Medicine.

Abstract
Full Text (subscription or payment may be required)

Providers Must Understand Legal Limits of Telemedicine

FRIDAY, Oct. 2, 2015 (HealthDay News) -- In order to minimize risk when practicing telemedicine, providers should ensure they hold the proper medical licenses, have medical liability insurance coverage, and communicate with patients regarding the potential risks of telemedicine, according to a report published in Medical Economics.

More Information

FDA Approves Keytruda for Advanced NSCLC

FRIDAY, Oct. 2, 2015 (HealthDay News) -- Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat advanced cases of non-small-cell lung cancer (NSCLC) with tumors that express the PD-L1 protein. Keytruda is approved for use with the PD-L1 IHC 22C3 pharmDx test, a companion diagnostic.

More Information

Palliative Radiotherapy Often Overused in Stage IV NSCLC

FRIDAY, Oct. 2, 2015 (HealthDay News) -- Stage IV nonsmall-cell lung cancer (NSCLC) patients in the United States often receive more radiation therapy than recommended, according to a study published online Sept. 30 in the Journal of the National Cancer Institute.

Abstract
Full Text (subscription or payment may be required)

FDA Approves New Combo Therapy for Melanoma

FRIDAY, Oct. 2, 2015 (HealthDay News) -- A new treatment for melanoma that combines two cancer drugs has been approved by the U.S. Food and Drug Administration. The therapy for advanced melanoma includes the drugs Yervoy (ipilimumab) and Opdivo (nivolumab), the Wall Street Journal reported.

Health Highlights: Oct. 2, 2015

MRI Effectively Measures Hemochromatosis Iron Burden

FRIDAY, Oct. 2, 2015 (HealthDay News) -- Magnetic resonance imaging (MRI) is an accurate and safe tool for the detection of low levels of iron overload in patients with hereditary hemochromatosis, according to a letter to the editor published online Sept. 11 in the American Journal of Hematology.

Abstract
Full Text (subscription or payment may be required)

CT Scans for Lung Cancer Result in Few False-Positives

THURSDAY, Oct. 1, 2015 (HealthDay News) -- Surgical intervention for a non-lung cancer diagnosis is rare following low-dose computed tomography (CT) screening for lung cancer, according to a study published in the October issue of the Annals of Thoracic Surgery.

Abstract
Full Text (subscription or payment may be required)

Strategies Provided for Improving EHR Efficiency

THURSDAY, Oct. 1, 2015 (HealthDay News) -- Several strategies can be implemented in order to better use electronic health records (EHRs) for patient care and efficiency, according to an article published in Medical Economics.

More Information

Too Few Women Getting Counseling Before BRCA Test

THURSDAY, Oct. 1, 2015 (HealthDay News) -- Only about one-third of women receive genetic counseling before they undergo testing for BRCA mutations, and patients who receive genetic counseling beforehand display better knowledge of the process and possible results, according to a study published online Oct. 1 in JAMA Oncology.

Abstract
Full Text
Editorial

Adjuvant Hormone Tx Ups Survival in Epithelial Ovarian CA

THURSDAY, Oct. 1, 2015 (HealthDay News) -- For women with epithelial ovarian cancer, adjuvant hormone therapy (AHT) for five years is associated with improved survival, according to a study published online Sept. 28 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)

Integrative Model Is Advised for Cancer Control in Primary Care

THURSDAY, Oct. 1, 2015 (HealthDay News) -- An integrative model incorporating cancer care into primary care is recommended for addressing the increasing burden of cancer control, according to a commission piece published online Sept. 29 in The Lancet Oncology.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Dermatography Helps Lessen Appearance of Surgical Scars

Dermatography Helps Lessen Appearance of Surgical Scars

Pigments can restore more natural skin appearance that patients are happy with

Drug-Resistant Bacteria Live in America's Water Systems

Drug-Resistant Bacteria Live in America's Water Systems

Bacteria found in plumbing may sicken thousands each year

Deep Brain Stimulation May Improve TBI Symptoms

Deep Brain Stimulation May Improve TBI Symptoms

Deep brain stimulation appears to boost function and quality of life

is free, fast, and customized just for you!

Already a member?

Sign In Now »